A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
about
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsAzathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseFolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.Indian Society of Gastroenterology consensus statements on Crohn's disease in India.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment.Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.Identification of inflammatory bowel disease-related proteins using a reverse k-nearest neighbor search.Pediatric Crohn's Disease in Bahrain
P2860
Q26785537-0CCFCA43-2ED3-4AF9-B5D6-2942DA09B028Q34993024-EADBCB29-D6B2-48F8-8217-50A9D8EA28F1Q35973766-2A341144-14EE-4279-9FEA-D9632A6F8C84Q37334837-E7FA7681-AE48-4F6C-8309-6FFEF99ED434Q38378837-2397E51A-14CD-4C7C-B26E-FEA6FE3A8BDBQ49508046-A190E025-B82D-4559-94C7-99179C5724CBQ49821178-CB4DB604-27D7-416C-B95E-ED398A34C420Q50098797-5E04EE56-3011-4CAD-A00D-0F647572C24CQ50098937-B6553FF5-49C8-46CC-8C86-31EA64DAD8EFQ51051024-71F1F690-8E04-493E-8EB5-CB9319994A3AQ57100278-89934DB6-061A-4449-9C8B-19A41D32DA75
P2860
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@en
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@nl
type
label
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@en
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@nl
prefLabel
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@en
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@nl
P2093
P2860
P921
P356
P1476
A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.
@en
P2093
Adérson Omar Mourão Cintra Damião
André Luiz Tavares Pinto
Júlio Maria Fonseca Chebli
Liliana Andrade Chebli
Orlando Ambrogini Júnior
Pedro Duarte Gaburri
Tarsila Campanha da Rocha Ribeiro
P2860
P304
P356
10.12659/MSM.890331
P577
2014-03-26T00:00:00Z